Application no. and date | 18158907.8 (espacenet) (Federated) (European Patent Register), 20070626 | Patent/reg. no. and date | DK/EP 3357911, 20220511 | Publication date | 20180808 | Priority no. and date | US 816522 P, 20060626 | EP pub. no. and date |
EP 3357911 20180808 | Effective date | | Applicant/owner | Akebia Therapeutics Inc., 245 First Street, Suite 1100
Cambridge, MA 02142, US | Applicant ref. no. | P80133DK01 | Inventor | Kawamoto, Richard Masaru, 7584 Cedar Mountain Road
Divide, CO 80814, US, Wu, Shengde, 4305 Mackenzie Court
Mason, OH 45040, US, Warshakoon, Namal, Chithranga, 504 Summer Harvest Court
Cary, NC 27519, US, Boyer, Angelique, Sun, 10558 Stablehand Dr.
Cincinatti, OH 45242, US, Greis, Kenneth, Donald, Vontz Center for Molecular Studies 3125 Eden Ave.
Cincinatti, OH 45267, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 31/4418 (2006.01) , A61P 35/00 (2006.01) , C07D 213/81 (2006.01) | Title | PROLYLHYDROXYLASEINHIBITORER OG FREMGANGSMÅDER TIL ANVENDELSE | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|